These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The problem of dose-response and therapeutic ratio of inhaled steroids. Edsbäcker S Am J Respir Crit Care Med; 2001 Jun; 163(7):1758-9. PubMed ID: 11458876 [No Abstract] [Full Text] [Related]
23. [Effectiveness of topical application of a new corticoid-like preparation]. Chebotarev VV Vestn Dermatol Venerol; 1981 Mar; (3):67-9. PubMed ID: 7257602 [No Abstract] [Full Text] [Related]
24. What's new in topical therapy? Manick KP Minn Med; 1974 Oct; 57(10):853-6. PubMed ID: 4607514 [No Abstract] [Full Text] [Related]
25. Corticosteroids in the treatment of skin disorders. Wheeler CE; Briggaman RA; Puritz EM Am Fam Physician; 1973 Jan; 7(1):130-40. PubMed ID: 4682971 [No Abstract] [Full Text] [Related]
26. [Alternating administration in external therapy with corticosteroids in daily practice]. Lohfink HD; Lehmann C Z Arztl Fortbild (Jena); 1984; 78(17):721-3. PubMed ID: 6239459 [No Abstract] [Full Text] [Related]
27. [Topical corticoids for children: how to prescribe?]. Stalder JF Rev Infirm; 1999 Jan; (45):48-51. PubMed ID: 10410071 [No Abstract] [Full Text] [Related]
28. [Clinical effectiveness of fluocinonide in several skin diseases]. Tomoka MT; Ochoa AG Wien Med Wochenschr; 1973 Apr; 123(15):247-8. PubMed ID: 4267190 [No Abstract] [Full Text] [Related]
29. Topical glucocorticosteroids. Fritz KA; Weston WL Ann Allergy; 1983 Feb; 50(2):68-76. PubMed ID: 6337530 [TBL] [Abstract][Full Text] [Related]
30. [Cutaneous complications of inhaled corticoids]. Guillot B; Godard P Ann Dermatol Venereol; 1998 Dec; 125(12):927-30. PubMed ID: 9922874 [No Abstract] [Full Text] [Related]
31. Ranking of topical glucocorticoids. Principles and results. Smith EW; Haigh JM Curr Probl Dermatol; 1993; 21():89-96. PubMed ID: 8299381 [No Abstract] [Full Text] [Related]
32. [External therapy with glucocorticosteroids]. Przybilla B; Ring J Med Monatsschr Pharm; 1983 Jul; 6(7):195-205. PubMed ID: 6888314 [No Abstract] [Full Text] [Related]
34. Benefit versus risk for oral, inhaled, and nasal glucocorticosteroids. Mortimer KJ; Tattersfield AE Immunol Allergy Clin North Am; 2005 Aug; 25(3):523-39. PubMed ID: 16054541 [TBL] [Abstract][Full Text] [Related]
35. [Fluocinonid--a new corticoid for the dermatologic local therapy]. Weitgasser H Z Haut Geschlechtskr; 1972 Mar; 47(6):231-4. PubMed ID: 5019023 [No Abstract] [Full Text] [Related]
36. [Lupoid form of rosacea-like dermatitis]. Marghescu S Hautarzt; 1988 Jun; 39(6):382-3. PubMed ID: 2969880 [TBL] [Abstract][Full Text] [Related]
37. [Materials on clinical and experimental study of certain aerosols]. Smelov NS; Samsonov VA; Ievleva EA Vestn Dermatol Venerol; 1975 Jul; (7):48-51. PubMed ID: 1217162 [No Abstract] [Full Text] [Related]
38. [Local glucocorticoid therapy of nonspecific inflammatory diseases of the joints (a review of the literature)]. Lomnitskiĭ OIa; Derzhavin NK; Ternovoĭ NK Vrach Delo; 1985 Jul; (7):70-5. PubMed ID: 3901517 [No Abstract] [Full Text] [Related]
39. Treatment of hyperkeratotic dermatitis of the palms. Sequential treatment with a keratolytic gel and corticosteroid ointment. Baden HP Arch Dermatol; 1974 Nov; 110(5):737-8. PubMed ID: 4424786 [No Abstract] [Full Text] [Related]
40. [Antiinflammatory effect of a topical corticosteroid: known brand versus generic drug]. Castanedo-Cázares JP; Quistián-Galván J; Torres-Alvarez B; Torres-Ruvalcaba A; Moncada B Gac Med Mex; 2001; 137(4):311-4. PubMed ID: 11519354 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]